Target intelligence / Profile preview

MicroRNA 1255b-1 (MIR1255B1)

Target
MIR1255B1
Molecular classification
microRNA, Non-coding RNA, miR-125 family member
01

Overview

MicroRNA 1255b-1 is a member of the miR-125 family, encoded by the MIR1255B1 gene and classified as a non-coding microRNA involved in regulatory functions at the post-transcriptional level[1][2]. Like other miR-125 family members, MIR1255B1 acts by incorporating into the RNA-induced silencing complex (RISC) to inhibit or destabilize target mRNAs through imperfect base pairing, thereby influencing processes such as cell differentiation, proliferation, apoptosis, and immune responses[1][3]. The miR-125 family, which includes MIR1255B1, has been implicated in both tumor suppressive and tumor promoting roles depending on disease context, particularly in various carcinomas and hematologic cancers such as B-cell acute lymphoblastic leukemia and acute myeloid leukemia[3]. While members of the miR-125 family are being explored as therapeutic targets and disease biomarkers, MIR1255B1 itself is primarily studied for its biological functions and disease associations rather than as a direct drug target[1][3][6].

Other names
hsa-mir-1255b-1MIRN1255B1MIR1255B-1
02

Biological functions

Post-transcriptional gene regulationCell differentiationCell proliferationApoptosisImmune response
03

Disease associations

Cancer (tumor suppression and promotion, especially in leukemia and carcinoma)Immune system disordersOther (potentially implicated in neurological disorders and muscle abnormalities via the miR-125 family)
04

Safety considerations

Off-target effects (general for microRNA therapeutics)Delivery issues (general for microRNA therapeutics)
05

Biomarkers

Potential biomarker for cell differentiation, proliferation, apoptosis, immune response, and especially in cancer types including leukemia and carcinomas

Beyond the preview

Go deeper on MicroRNA 1255b-1 (MIR1255B1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 1255b-1 (MIR1255B1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call